To edit, sign in as emanesis@gmail.com.
Follow
Ketikoglou Ioannis
Ketikoglou Ioannis
Athens Greece
No verified email
Title
Cited by
Cited by
Year
Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral (s …
GV Papatheodoridis, S Manolakopoulos, G Touloumi, G Vourli, ...
Gut, gut. 2010.221846, 2011
2082011
Molecular epidemiology of hepatitis C virus (HCV) in Greece: Temporal trends in HCV genotype‐specific incidence and molecular characterization of genotype 4 isolates
A Katsoulidou, V Sypsa, NC Tassopoulos, J Boletis, A Karafoulidou, ...
Journal of viral hepatitis 13 (1), 19-27, 2006
1182006
Extensive psoriasis induced by pegylated interferon alpha-2b treatment for chronic hepatitis B.
I Ketikoglou, S Karatapanis, I Elefsiniotis, G Kafiri, A Moulakakis
European journal of dermatology: EJD 15 (2), 107-109, 2005
712005
Impact of interferon‐alpha therapy on liver fibrosis progression in patients with HBeAg‐negative chronic hepatitis B
GV Papatheodoridis, K Petraki, E Cholongitas, E Kanta, I Ketikoglou, ...
Journal of viral hepatitis 12 (2), 199-206, 2005
532005
Reconstructing and predicting the hepatitis C virus epidemic in Greece: increasing trends of cirrhosis and hepatocellular carcinoma despite the decline in incidence of HCV …
V Sypsa, G Touloumi, NC Tassopoulos, I Ketikoglou, I Vafiadis, G Hatzis, ...
Journal of viral hepatitis 11 (4), 366-374, 2004
512004
Future trends of HCV-related cirrhosis and hepatocellular carcinoma under the currently available treatments
V Sypsa, G Touloumi, GV Papatheodoridis, NC Tassopoulos, I Ketikoglou, ...
JOURNAL OF HEPATOLOGY 40, 84-84, 2004
512004
The effect of adherence to therapy on sustained response in daily or three times a week interferon alpha‐2b plus ribavirin treatment of naive and nonresponder chronic hepatitis …
M Raptopoulou, D Tsantoulas, I Vafiadi, I Ketikoglou, E Paraskevas, ...
Journal of viral hepatitis 12 (1), 91-95, 2005
502005
Hepatocellular carcinoma risk in HB eAg‐negative chronic hepatitis B patients with or without cirrhosis treated with entecavir: HepNet. Greece cohort
GV Papatheodoridis, S Manolakopoulos, G Touloumi, G Nikolopoulou, ...
Journal of viral hepatitis 22 (2), 120-127, 2015
462015
Future trends of HCV‐related cirrhosis and hepatocellular carcinoma under the currently available treatments
V Sypsa, G Touloumi, GV Papatheodoridis, NC Tassopoulos, I Ketikoglou, ...
Journal of viral hepatitis 12 (5), 543-550, 2005
462005
Hepatic parenchyma resection using stapling devices: peri-operative and long-term outcome
SG Delis, A Bakoyiannis, D Karakaxas, K Athanassiou, N Tassopoulos, ...
HPB 11 (1), 38-44, 2009
342009
Autoimmune pancreatitis
I Ketikoglou, A Moulakakis
Digestive and liver disease 37 (3), 211-215, 2005
302005
Patient's age modifies the impact of the proposed predictors of sustained virological response in chronic hepatitis C patients treated with PEG-interferon plus ribavirin
IS Elefsiniotis, C Pavlidis, I Ketikoglou, S Koutsounas, N Scarmeas, ...
European journal of internal medicine 19 (4), 266-270, 2008
282008
HEPNET. Greece Cohort Study Group. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with …
GV Papatheodoridis, S Manolakopoulos, G Touloumi, G Vourli, ...
Gut 60 (8), 1109-1116, 2011
262011
Predictors of sustained virological response in Greek and Egyptian patients with hepatitis C genotype 4: does ethnicity matter?
V Papastergiou, D Dimitroulopoulos, L Skorda, P Lisgos, I Ketikoglou, ...
Journal of medical virology 84 (8), 1217-1223, 2012
242012
Immunogenicity of recombinant hepatitis B vaccine in treatment-naive and treatment-experienced chronic hepatitis C patients: the effect of pegylated interferon plus ribavirin …
IS Elefsiniotis, E Vezali, K Kamposioras, KD Pantazis, R Tontorova, ...
World Journal of Gastroenterology: WJG 12 (27), 4420, 2006
242006
Hepatitis C virus survival curve analysis in naive patients treated with peginterferon alpha-2b plus ribavirin. A randomized controlled trial for induction with high doses of …
K Mimidis, VP Papadopoulos, I Elefsiniotis, D Koliouskas, I Ketikoglou, ...
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES 15 (3), 213, 2006
232006
Listeria monocytogenes peritonitis: presentation, clinical features, treatment, and outcome
GD Liatsos, S Thanellas, M Pirounaki, I Ketikoglou, A Moulakakis
Scandinavian journal of gastroenterology 47 (10), 1129-1140, 2012
212012
Hepatitis C virus genotyping in Greece: unexpected high prevalence of genotype 5a in a Greek island
S Karatapanis, P Tsoplou, V Papastergiou, A Vasiageorgi, M Stampori, ...
Journal of medical virology 84 (2), 223-228, 2012
202012
Long‐term adefovir plus lamivudine therapy does not decrease creatinine clearance in HBeAg‐negative chronic hepatitis B patients
S Manolakopoulos, A Striki, M Deutsch, M Mela, I Ketikoglou, ...
Liver International 31 (10), 1525-1532, 2011
172011
A randomized trial to assess the efficacy of interferon alpha in combination with ribavirin in the treatment of interferon alpha nonresponders with chronic hepatitis C …
NC Tassopoulos, D Tsantoulas, M Raptopoulou, T Vassiliadis, ...
Journal of viral hepatitis 10 (3), 189-196, 2003
172003
The system can't perform the operation now. Try again later.
Articles 1–20